Sutimlimab Biosimilar - Research Grade
Product Sizes
1 mg
ICH5012-1MG
5 mg
ICH5012-5MG
10 mg
ICH5012-10MG
20 mg
ICH5012-20MG
50 mg
ICH5012-50MG
100 mg
ICH5012-100MG
200 mg
ICH5012-200MG
500 mg
ICH5012-500MG
1 g
ICH5012-1G
About this Product
- SKU:
- ICH5012
- Application:
- Cell-based/Functional Assay
- CE/IVD:
- RUO
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 5 mg/ml
- Extra Details:
- RUO sutimlimab biosimilar is a humanized monoclonal antibody that is designed to selectively target and inhibit C1s in the classical complement pathway, which is part of the innate immune system. By blocking C1s, sutimlimab inhibits the activation of the classical complement pathway with the goal of halting C1-activated hemolysis in cold agglutinin disease to prevent the abnormal destruction of healthy red blood cells. By selectively inhibiting the classical pathway upstream at C1s, sutimlimab does not inhibit the lectin and alternative complement pathways.
- Formulation:
- Sterile, preservative-free, solution in PBS. BSA and Azide free.
- Immunogen:
- C1s
- Isotype:
- IgG4
- Purity:
- >95%
- Purification:
- Protein A/G Purified
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Specificity:
- Detects human C1s. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Sutimlimab.
- Storage Conditions:
- -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ichorbio
- Type:
- Antibody: Biosimilar Antibody
- Shipping Costs:
- Free shipping to UK Customers
- Manufacturer's Data Sheet:https://ichor.bio/productpdf/print/index/url_key/sutimlimab-biosimilar-research-grade/
